FDA Technical Corrections Bill Could Clarify Trial Registry Requirements
This article was originally published in The Pink Sheet Daily
Executive Summary
Clinical trial registry requirements contained in the recently enacted FDA Amendments Act are likely to be clarified in a "technical corrections" bill in the coming weeks, according to device industry lobbyists.